Regional Blood Flow Completed Phase 2 Trials for Moxaverine (DB12251)

IndicationStatusPhase
DBCOND0033542 (Regional Blood Flow)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00709423Effects of Moxaverine and Placebo on Ocular Blood FlowTreatment